Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
filingDate |
2001-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cffb44082220de55d755db0cc471fd4d |
publicationDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002052394-A1 |
titleOfInvention |
Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release |
abstract |
The combination of the antihypertensive calcium channel blocker amlodipine and lipid-lowering agent atorvastatin inhibits free cholesterol crystallization in atherosclerotic-like membranes. In addition, treatment with a combination of amlodipine and atorvastatin results in a synergistic effect on the release of NO from rabbit aorta endothelial cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439618-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717504-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285127-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712428-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712429-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400069-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369582-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464757-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690820-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547710-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446269-B2 |
priorityDate |
2000-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |